Skip to main content
. 2012 Nov 1;3(6):406–410. doi: 10.6004/jadpro.2012.3.6.8

Table 1.

Table 1

Table 1. Summary of Efficacy and Rates of Peripheral Neuropathy in Patients With Relapsed Multiple Myeloma Treated With SC vs. IV Bortezomib (n = 222)